involve the creation of artificial APCs to prime the adaptive immune system to target malignant cells. Antigen-presenting cells fall into two categories:... 16 KB (2,128 words) - 09:55, 4 March 2024 |
Artificial antigen presenting cells (aAPCs) are engineered platforms for T-cell activation. aAPCs are used as a new technology and approach to cancer... 11 KB (1,426 words) - 21:50, 22 April 2024 |
biology, chimeric antigen receptors (CARs)—also known as chimeric immunoreceptors, chimeric T cell receptors or artificial T cell receptors—are receptor... 76 KB (8,019 words) - 21:29, 13 April 2024 |
number of other particles can qualify as artificial cells. The terms "artificial cell" and "synthetic cell" are used in a variety of different fields... 59 KB (8,250 words) - 21:50, 22 April 2024 |
Antibody (redirect from Receptors, antigen, b-cell) specific cell types and cytokines to persist. Plasma cells will secrete huge quantities of antibody regardless of whether or not their cognate antigen is present... 118 KB (13,288 words) - 23:16, 30 March 2024 |
Adaptive immune system (section Antigen presentation) dendritic cell.[citation needed] With the exception of non-nucleated cells (including erythrocytes), all cells are capable of presenting antigen through... 55 KB (6,950 words) - 14:57, 28 March 2024 |
Immune tolerance (redirect from Self-antigen) upon T cell activation, and TGF-β from any of a variety of sources, including tolerizing dendritic cells (DCs), other antigen presenting cells, or in... 50 KB (6,022 words) - 11:37, 4 March 2024 |
Cancer vaccine (redirect from Tumor antigen vaccine) normal cells but are activated in cancer cells or peptides containing cancer-specific mutations. Antigen-presenting cells (APCs) such as dendritic cells take... 27 KB (3,127 words) - 20:07, 24 April 2024 |